PMC3350165_01
Axial noncontrast CT section through the abdomen showing splenomegaly with multiple hyperdense nodules in the splenic parenchyma (arrowheads).
CRIM.ONCMED2011-298357.001.jpg
PMC3350165_01_CRIM.ONCMED2011-298357.001.jpg
fig1
Noncontrast CT abdomen showed massive splenomegaly with multiple hyperdense foci within the spleen (Figure 1, arrowheads) representing hemorrhage within the splenic parenchyma.
Lesions showing intense enhancement on post contrast CT images.
CRIM.ONCMED2011-298357.002.jpg
PMC3350165_01_CRIM.ONCMED2011-298357.002.jpg
fig2
Post contrast CT (Figure 2) revealed multifocal intensely enhancing areas in the splenic parenchyma suggesting the highly vascular nature of these masses.
Coronal postcontrast MR image showing splenomegaly with multiple intensely enhancing masses.
CRIM.ONCMED2011-298357.003.jpg
PMC3350165_01_CRIM.ONCMED2011-298357.003.jpg
fig3
On postcontrast MRI, there was central enhancement of these lesions (Figure 3) with intralesional traversing blood vessels (not shown).
Axial PET CT image showing FDG uptake in the lesions suggestive of high metabolic activity.
CRIM.ONCMED2011-298357.004.jpg
PMC3350165_01_CRIM.ONCMED2011-298357.004.jpg
fig4
 Bone marrow biopsy, however, revealed a B-cell lymphoma and an initial staging PET scan showed massively enlarged spleen with increased FDG uptake (Figure 4) with an SUV of 6.23 consistent with lymphoma or other malignant process.